780
A. S. Demir et al. / Tetrahedron: Asymmetry 15 (2004) 777–781
66.9 mmol) and benzene (200 mL) were heated under
reflux for 30–54 h. After cooling, the reaction mixture
was first filtered and then washed with satd NaHCO3
solution. The mixture was then dried over MgSO4,
concentrated and purified by flash column chromato-
graphy (2:1 EtOAc/hexane) to yield rac-1a and rac-2a.
4.2.3. General procedure for reductions. To a suspension
of LiAlH4 (66.8 mg, 1.8 mmol) in anhydrous Et2O
(50 mL) was added acetoxy enone (1 mmol) or hydroxy
enone (1 mmol) at rt over 15 min. The mixture was re-
fluxed for 30–50 min, cooled to rt and quenched with
water and 10% H2SO4. The organic phase was washed
with satd NaHCO3 solution and brine and then dried
over MgSO4. After evaporation of the solvent flash
column chromatography (EtOAc) was performed to
obtain 4-hydroxy cyclic enones 3 and 4 in 79–81% yield.
4.2.2. General procedure for the lipase-catalyzed asym-
metric hydrolysis of rac-1a and rac-2a. Lipase (200–
300 mg) was dissolved in a potassium phosphate buffer
(20 mM, pH 7, 30 mL) and added to a solution of the
pure substrate 1a and 2a (1 mmol) in DMSO (3 mL) and
the reaction mixture left to stir at rt. The reaction was
monitored by TLC and HPLC and when maximum
conversion was reached, the reaction was terminated by
filtration. The unreacted acetate and product were sep-
arated by flash chromatography over silica (n-hexane/
ethyl acetate, 4:1).
4.2.3.1. (R)-4-Hydroxy-2-methyl-2-cyclohexen-1-one,
(R)-3.3;5 Light yellow semi-solid. (100 mg, 79%);
20
½aꢁ ¼ +46.7 (c 0.1, CHCl3); IR (CHCl3): m ¼ 3300,
D
1715, 1635 cmꢀ1. 1H NMR (400 MHz, CDCl3) d 1.73 (t,
J ¼ 1:3 Hz, 3H, Me-2), 1.88 (m, 1H, H-5), 2.27 (m, 2H,
H-5 + H-6), 2.53 (m, 1H, H-6), 4.44 (m, 1H, H-4), 6.60
(m, 1H, H-3); 13C NMR (100 MHz, CDCl3) d 15.6, 32.7,
35.3, 66.4, 135.6, 147.7, 199.1.
4.2.3.2. (S)-4-Hydroxy-2-methylcyclopent-2-en-1-one,
4.2.2.1.
(S)-6-Acetoxy-3-methoxy-2-methyl-2-cyclo-
20
D
(S)-4.6 Yellow oil (91 mg). ½aꢁ ¼ )33.5 (c 1.1, CHCl3)
hexen-1-one, (S)-1a.2d Yellow semi-solid. (97 mg);
20
{lit.6 ½aꢁ ¼ )30.0 (c 1.2, CHCI3)}; IR (CHCI3):
20
½aꢁ ¼ )87.9 (c 0.6, CHCl3); IR (CHCl3): m ¼ 1735,
D
D
m ¼ 3400, 1710, 1640 cmꢀ1. 1H NMR (400 MHz, CDCl3)
d 1.74 (s, 3H, CH3), 2.07 (br s, 1H, OH), 2.2 (dd,
J ¼ 18:5, 1.8 Hz, 1H, CH2), 2.71 (dd, J ¼ 18:5, 6.07 Hz,
1H, CH2), 4.85 (m, 1H, CHOH), 7.09 (m, 1H, @CH);
13C NMR (100 MHz, CDCI3) d 206.2, 156.7, 144.0, 68.8,
44.8, 10.3.
1640, 1610 cmꢀ1; 1H NMR (400 MHz, CDCl3) d 1.61 (s,
3H, CH3), 1.99 (ddd, J ¼ 24:0, 12.5, 5.7 Hz, 1H, H-5),
2.09 (s, 3H, COCH3), 2.19 (m, 1H, H-5), 2.60 (m, 1H, H-
4), 2.70 (m, 1H, H-4), 3.77 (s, 3H, OCH3), 5.15 (dd,
J ¼ 12:9, 5.1 Hz, 1H, H-6); 13C NMR (100 MHz,
CDCl3) d 8.0, 21.2, 23.9, 26.7, 55.5, 72.3, 114.2, 170.2,
170.3, 192.5.
Acknowledgements
4.2.2.2. (R)-6-Hydroxy-3-methoxy-2-methyl-2-cyclo-
hexen-1-one, (R)-1b. Colorless semi-solid. (73 mg).
20
Financial support was funded by the Middle East
Technical University (BAP-2003), the Scientific and
Technical Research Council of Turkey (TUBITAK), the
Turkish Academy of Sciences (TUBA), and the Turkish
State Planning Organization (DPT) and is gratefully
acknowledged. We would like to thank MEITO SAN-
GYO Co., Ltd., Tokyo, Japan for the enzymes TL, SL,
and QLM.
½aꢁ ¼ +167.3 (c 0.3, CHCl3); IR (CHCl3): m ¼ 3250,
D
1650, 1620 cmꢀ1; 1H NMR (400 MHz, CDCl3) d 1.64 (s,
3H, CH3), 1.69 (ddd, J ¼ 5:4, 12.4, 25.5 Hz, 1H, H-5),
2.34 (m, 1H, H-5), 2.54 (m, 1H, H-4), 2.68 (m, 1H, H-4),
3.79 (s, 3H, OCH3), 3.88 (dd, J ¼ 5:4, 13.3 Hz, 1H, H-
6); 13C NMR (100 MHz, CDCl3) d 8.0, 24.0, 29.4, 55.4,
71.0, 112.4, 171.5, 198.8. Anal. Calcd for C8H12O3
(156.18): C, 61.52; H, 7.74. Found: C, 61.21; H, 7.98.
4.2.2.3.
(R)-4-Methoxy-3-methyl-2-oxocyclopent-3-
en-1-yl acetate, (R)-2a.2d;e Yellow oil (83 mg).
20
References and notes
½aꢁ ¼ +32.1 (c 0.01, CHCI3); IR (CHCl3): m ¼ 1750,
D
1710, 1630 cmꢀ1. 1H NMR (400 MHz, CDCl3) d 1.58 (s,
3H, CH3), 2.05 (s, 3H, COCH3), 2.43 (dd, J ¼ 17:4,
1.5 Hz, 1H, CH2), 3.14 (ddd, J ¼ 17:4, 6.8, 1.5 Hz, 1H,
CH2), 3.9 (s, 3H, OCH3), 5.03 (dd, J ¼ 6:8, 2.5 Hz, 1H,
CH); 13C NMR (100 MHz, CDCI3) d 197.5, 179.9,
169.2, 114.4, 69.9, 55.7, 31.9, 19.6, 4.9.
1. (a) Noyori, R.; Suzuki, M. Angew. Chem., Int. Ed. Engl.
1984, 23, 847, and references cited therein; (b) Collins,
P. W.; Djuric, S. W. Chem. Rev. 1993, 93, 1533; (c) Dols,
P. P. M. A.; Klunder, A. J. H.; Zwanenburg, B. Tetra-
hedron 1994, 50, 8515; (d) Coppola, G. M.; Schuster, H. F.
a-Hydroxy Acids in Enantioselective Synthesis; VCH:
Weinheim, 1997; (e) Davies, F. A.; Chen, B. C. Chem.
Rev. 1992, 92, 919; (f) Mabuchi, H.; Haba, T.; Tatami, R.;
Miyamoto, S.; Sakai, Y.; Wakasugi, T.; Watanabe, A.;
Koizumi, J.; Takeda, R.. New Engl. J. Med. 1981, 305,
478.
2. (a) Matoba, K.; Maeda, T.; Nagase, K.; Yamazaki, T.
Chem. Pharm. Bull. 1976, 24, 165; (b) Katsube, J.; Matsui,
M. Agric. Biol. Chem. 1971, 353, 401; (c) Canonica, L.;
Corbella, A.; Jommi, G.; Pelizzoni, F.; Scolastico, C.
Tetrahedron Lett. 1966, 26, 3031; (d) Demir, A. S.; Sayrac,
T.; Watt, D. S. Synthesis 1990, 1119; (e) Kitamoto, M.;
4.2.2.4. (S)-5-Hydroxy-3-methoxy-2-methylcyclopent-
2-en-1-one, (S)-2b.12 Colorless solid (47 mg). Mp 155–
20
157 (lit.12 158–161 °C). ½aꢁ ¼ +78.8 (c 0.1, CHCl3); IR
D
(CHCl3): m ¼ 3450, 1710, 1640 cmꢀ1
.
1H NMR
(400 MHz, CDCl3) d 1.58 (t, 3H, J ¼ 1:9, CH3), 2.48 (dt,
J ¼ 17:0, 1.9 Hz, 1H, CH2), 2.96 (ddd, J ¼ 17:0, 6.5,
1.9 Hz, 1H, CH2), 3.33 (br s, OH), 3.92 (s, 3H, OCH3),
4.17 (d, J ¼ 6:5 Hz,1H, CH); 13C NMR (100 MHz,
CDCI3) d 205.0, 182.2, 115.2, 70.9, 57.1, 34.3, 6.2.